About GBI
GBI is a Healthcare company based in Shanghai (China) founded in 2002, and was acquired by Baidu in February 2023. Drugs data, market research, and patient voice services are provided. It operates on a Data-as-a-Service and Subscription Services model. The company has 1 employees. GBI offers products and services including GBI SOURCE, GBI METRIX, GBI DEVINT, GBI MediListen, and GBI Business Intelligence Service. Its focus areas include Health Information Services and Medical Data Analytics. Its legal entity is Shanghai Jibo Investment Management Consulting Co., Ltd.
Company details
Comprehensive medical data and intelligence solutions are offered by GBI. Focus is placed on global drug databases, researcher insights, medical device competition solutions, and pharmaceutical sentiment monitoring. Services cater to the healthcare industry, including pharmaceuticals, medical devices, CROCDMO, investment, and consulting sectors. Customized business intelligence solutions are also provided to support market analysis, patient insights, and marketing strategies across the healthcare ecosystem.
- Headquarters Shanghai, China
- Employees 1
- Stage Acquired
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website gbihealth.com.cn
- Social LinkedIn X
- Acquired by Baidu (Feb 2023)
- Legal Name Shanghai Jibo Investment Management Consulting Co., Ltd.
Products & Services of GBI
GBI offers a comprehensive portfolio of products and services, including GBI SOURCE, GBI METRIX, GBI DEVINT, GBI MediListen, and GBI Business Intelligence Service.
Global drug database covering entire lifecycle is provided.
Researcher database with holistic insights is offered widely.
Medical device competition solutions are delivered for professionals.
Pharmaceutical sentiment monitoring solutions are provided for industry.
Customized healthcare industry solutions are offered for clients.
Investors in GBI
GBI has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Baidu.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
AI-enabled keyword-based search engine is operated for information retrieval. | 2000 | baidu.com | Beijing, China |
Investor details for GBI
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of GBI
2 dated milestones of GBI across 21 years, from founding to its latest funding, stage changes and deals.
- Founded GBI is founded.
- Exit Acquired by Baidu.
Web traffic of GBI
The website of GBI (gbihealth.com.cn) receives about 3.7K visits a month.
- Monthly visits3.7K
▲ 37.2% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about GBI
GBI was founded in 2002.
GBI is headquartered in Shanghai, China.
Comprehensive medical data and intelligence solutions are offered by GBI. Focus is placed on global drug databases, researcher insights, medical device competition solutions, and pharmaceutical sentiment monitoring. Services cater to the healthcare industry, including pharmaceuticals, medical devices, CROCDMO, investment, and consulting sectors. Customized business intelligence solutions are also provided to support market analysis, patient insights, and marketing strategies across the healthcare ecosystem.
GBI offers GBI SOURCE, GBI METRIX, GBI DEVINT, GBI MediListen, and GBI Business Intelligence Service.
GBI has 1 investor. Key investors include Baidu.
GBI operates through Shanghai Jibo Investment Management Consulting Co., Ltd..
Yes. GBI was acquired by Baidu in February 2023.
